Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 12Sanofi-Aventis Canada Inc.
01 52747123
02 52841588
03 22955304
01 12ALIROCUMAB
01 12SOLUTION
01 11932-07-27
02 11935-07-16
03 52029-12-15
04 42032-07-27
05 12035-07-16
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 1932-07-27
Date Granted : 2019-09-03
Brand Name : PRALUENT
Patent Number : 2841588
Filing Date : 2012-07-27
Strength per Unit : 300 mg / 2mL (pre - filled pen)
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 1932-07-27
Date Granted : 2019-09-03
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 1935-07-16
Date Granted : 2023-12-12
Brand Name : PRALUENT
Patent Number : 2955304
Filing Date : 2015-07-16
Strength per Unit : 300 mg / 2mL (pre - filled pen)
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 1935-07-16
Date Granted : 2023-12-12
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2029-12-15
Date Granted : 2018-01-09
Brand Name : PRALUENT
Patent Number : 2747123
Filing Date : 2009-12-15
Strength per Unit : 300 mg / 2mL (pre - filled pen)
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2029-12-15
Date Granted : 2018-01-09
Patent Expiration Date : 2029-12-15
Date Granted : 2018-01-09
Brand Name : PRALUENT
Patent Number : 2747123
Filing Date : 2009-12-15
Strength per Unit : 75 mg / ml (prefilled syringe)
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2029-12-15
Date Granted : 2018-01-09
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2032-07-27
Date Granted : 2019-09-03
Brand Name : PRALUENT
Patent Number : 2841588
Filing Date : 2012-07-27
Strength per Unit : 75 mg / ml (prefilled syringe)
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2032-07-27
Date Granted : 2019-09-03
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2029-12-15
Date Granted : 2018-01-09
Brand Name : PRALUENT
Patent Number : 2747123
Filing Date : 2009-12-15
Strength per Unit : 150 mg / mL (prefilled syringe)
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2029-12-15
Date Granted : 2018-01-09
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2032-07-27
Date Granted : 2019-09-03
Brand Name : PRALUENT
Patent Number : 2841588
Filing Date : 2012-07-27
Strength per Unit : 150 mg / mL (prefilled syringe)
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2032-07-27
Date Granted : 2019-09-03
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2029-12-15
Date Granted : 2018-01-09
Brand Name : PRALUENT
Patent Number : 2747123
Filing Date : 2009-12-15
Strength per Unit : 75 mg / mL (prefilled pen)
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2029-12-15
Date Granted : 2018-01-09
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2032-07-27
Date Granted : 2019-09-03
Brand Name : PRALUENT
Patent Number : 2841588
Filing Date : 2012-07-27
Strength per Unit : 75 mg / mL (prefilled pen)
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2032-07-27
Date Granted : 2019-09-03
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2029-12-15
Date Granted : 2018-01-09
Brand Name : PRALUENT
Patent Number : 2747123
Filing Date : 2009-12-15
Strength per Unit : 150 mg / mL (prefilled pen)
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2029-12-15
Date Granted : 2018-01-09
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
